Indian stocks: Visit www.stage2stocks.com →

Tectonic Therapeutic, Inc.

Stage 4 · Declining · week 1⚠ 3→4 today

As of Oct 22, 2026, Tectonic Therapeutic is in Stage 4, the downtrend phase, now in its first week (since Oct 22, 2026). It closed at $21.09, 44.4% below its 52-week high and below its 200-day average, which is rising.

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). More about the company

$21.09
-3.43% today
$412M · Small cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is TECX early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S3 14w
S2 22w
S1 14w
S2 17w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 13w → S3 14w → S4 13w → S1 6w → S2 6w → S3 2w → S2 22w → S3 8w → S4 10w → S1 14w → S4 11w → S1 9w → S2 17w → S3 4w → S2 11w → S3 5w → S4 1w current
Total tracked: 166 weeks across 17 stage runs.

TECX among Biotechnology151st of 591 by relative strength

All 591 →
Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#StockStageRS1M
1GTBPStage 2 · wk 799−22.3%
2IOVAStage 2 · wk 1899+38.8%
3SLSStage 3 · wk 499−1.5%
4MRNAStage 2 · wk 1799+11.3%
5TWSTStage 2 · wk 3999−14.5%
6KODStage 2 · wk 499+172.1%
7ERASStage 3 · wk 599+0.7%
8CLYMStage 3 · wk 399−15.8%
…151TECXStage 4 · wk 163−15.6%
vs 52W High
-44.4%
$16.44 lo$37.93 hi
44.4% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 1
1w13w26w
Week 1, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-24.9%
200 DMA: $28.09 · rising
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
1.07x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-15.6%
3M
-30.6%
6M
-25.8%
YTD
+0.9%
1Y
+11.1%
Scan Membership
Breakout Watch
Latest: 2024-09-05
7 appearances in last 60 days. First seen: 2019-08-28.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S43→4
Wk 1 · Vol 1.07x
2026-10-21S3
Wk 5 · Vol 0.63x
2026-10-20S3
Wk 5 · Vol 0.62x
2026-10-19S3
Wk 5 · Vol 0.86x
2026-10-16S3
Wk 5 · Vol 0.75x
2026-10-15S3
Wk 4 · Vol 0.81x
2026-10-14S3
Wk 4 · Vol 0.82x
2026-10-13S3
Wk 4 · Vol 0.71x
2026-10-12S3
Wk 4 · Vol 0.44x
2026-10-09S3
Wk 4 · Vol 0.47x
2026-10-08S3
Wk 3 · Vol 0.71x
2026-10-07S3
Wk 3 · Vol 1.30x
Moving averages & range
50 DMA
$27.83
200 DMA
$28.09
52W High
$37.93
52W Low
$16.44
5D Low
$20.65
Resistance levels (recent highs)
20d High
$23.67
60d High
$37.71
120d High
$37.93
250d High
$37.93
Next resistance
+12.2%
to 20d High
ROE
-33.8%
Profit margin 0.0%
Dividend Yield
0.00%
P/B 1.8

Tectonic Therapeutic: quick answers

What stage is Tectonic Therapeutic in?

As of Oct 22, 2026, Tectonic Therapeutic (TECX) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 22, 2026 and is in its first week there. What the four stages mean

Is Tectonic Therapeutic in an uptrend?

No. Tectonic Therapeutic is in a Stage 4 downtrend. It trades 24.9% below its 200-day average, which is rising.

How far is Tectonic Therapeutic from its 52-week high?

Tectonic Therapeutic closed at $21.09 on Oct 22, 2026, 44.4% below its 52-week high of $37.93. Its 52-week low is $16.44.

How has Tectonic Therapeutic performed over the past year?

As of Oct 22, 2026, Tectonic Therapeutic is up 11.1% over the past year and up 0.9% so far in 2026.

Which sector and industry is Tectonic Therapeutic in?

Tectonic Therapeutic is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.